Exploring serum and glucocorticoid-regulated kinase 1: A promising target for COVID-19 and atrial fibrillation treatment
Serum and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase that is involved in various cellular pathways, such as ion transport, cell survival, proliferation, and immune responses. Dysregulation of this enzyme is increasingly being associated with the progression of 2 prominent...
Saved in:
| Main Authors: | Jamal E-Fatima, PhD, Faez Iqbal Khan, PhD, Dakun Lai, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Heart Rhythm O2 |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666501825000807 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression profiles of SGK-1 and α-ENaC in minor salivary glands of subjects with xerostomia
by: Mahmood S. Mozaffari, et al.
Published: (2025-08-01) -
Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis
by: Jaime L. Rubin, et al.
Published: (2025-07-01) -
Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report
by: I. Sermet-Gaudelus, et al.
Published: (1999-01-01) -
India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges
by: Philip M. Farrell, et al.
Published: (2025-04-01) -
Evaluation of the Effectiveness of Using the CFTR Modulator Ivacaftor/Lumacaftor in Children with Cystic Fibrosis in the Sverdlovsk Region (Prospective Cohort Study)
by: Yuliya O. Vasenyova, et al.
Published: (2024-09-01)